Service contract for Illumina Miseq - new compete

The Food and Drug Administration has issued a forecast for a service contract to support the Illumina MiSeq platform, targeting new competition for maintenance and operational services. The contract is classified under NAICS code 811219, indicating it pertains to other commercial and industrial machinery and equipment repair and maintenance. The procurement is intended to ensure the continued functionality and reliability of the Illumina MiSeq system, which is critical for laboratory testing and research activities within the agency. No set-aside type has been specified, meaning the contract is open to all eligible vendors without preference for small businesses or other categories. Point of contact for this opportunity is the CBER Acquisition Liaison, reachable at cberacquisitions@fda.hhs.gov, with the Contracting Officer position currently listed as to be determined. The place of performance and physical location details are not provided, indicating the services may be delivered remotely or at multiple FDA facilities. The forecast was posted on May 25, 2026, and interested parties should monitor the HHS OSDBU portal for updates on the formal solicitation, as the opportunity remains in the pre-solicitation phase with no formal solicitation number assigned yet.